| # | Drug | Count |
|---|---|---|
| 0 | MARAVIROC | 2 |
| 1 | DARUNAVIR | 1 |
| 2 | DARUNAVIR 600 MG | 1 |
| 3 | DARUNAVIR 800 MG | 1 |
| 4 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 |
| 5 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1 |
| 6 | RILPIVIRINE | 1 |
| 7 | SPIRONOLACTONE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 2 | 0.0009 |
| 1 | DARUNAVIR 600 MG | 1 | 0.0002 |
| 2 | RILPIVIRINE | 1 | 0.0001 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 4 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 5 | DARUNAVIR | 1 | 0.0001 |
| 6 | SPIRONOLACTONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |